Unlocking KATs as Cancer Drug Targets: From Inhibitor Discovery to Translational Epigenomics jpiatt Thu, 09/03/2026 - 07:48 Wed, 10/14/2026 - 13:00 Resource Type Webinar Thomas Paul, Ph.D. Lysine acetyltransferases (KATs) are a family of enzymes involved in the epigenetic regulation of gene expression that represent a promising class of emerging drug targets for oncology. Potent and selective small molecule inhibitors of KAT family
CryptoAlerta — análise de criptomoedas e mercado em tempo real